Transitional cell carcinomas of the renal pelvis and the ureter: Comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population

BJU International

Volumn 103, Issue 3, 2009, Pages 312-316

  Tan, Lia Beng ^a,d   Chang, Lin Li ^b   Cheng, Kuang I ^b   Huang, Chun Hsiung ^b   Kwan, Aij Lie ^b,c  

^a Department of Urology   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Renal pelvis tumour; Taiwan; Upper tract urothelial carcinoma; Ureter tumour

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY PELVIS CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; PYELOGRAPHY; SENSITIVITY ANALYSIS; TAIWAN; TRANSITIONAL CELL CARCINOMA; URETER CARCINOMA;

AGE FACTORS; AGED; CARCINOMA, TRANSITIONAL CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; TAIWAN; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS;

EID: 58449112409     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07985.x     Document Type: Article

References (35)

1. Nocks BN, Heney NM, Daly JJ, Perrone TA, Griffin PP, Prout GR Jr. Transitional cell carcinoma of renal pelvis. Urology 1982 19 : 472 7
2. Hsieh YF, Ling GC, Lu YB, Yeh MT, Chiang CP. Incidence of tumor of the renal pelvis in Taiwan. Taiwan Yi Xue Hui Za Zhi 1979 78 : 749 53
3. Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 1999 85 : 1342 4
4. Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985 45 : 5895 9
5. Guo HR, Chiang HS, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 1997 8 : 545 50
6. Lamm SH, Byrd DM, Kruse MB, Feinleib M, Lai SH. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan. Biomed Environ Sci 2003 16 : 355 68
7. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, 5th edn. (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997 80 : 1803 4
8. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 48
9. Murphy DM, Zincke H, Furlow WL. Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter. J Urol 1980 123 : 629 31
10. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000 164 : 1523 5
11. Yang MH, Chen KK, Yen CC et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 2002 59 : 681 7
12. Mahony JF, Storey BG, Ibanez RC, Stewart JH. Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Aust NZ J Med 1977 7 : 463 9
13. McLaughlin JK, Silverman DT, Hsing AW et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 1992 52 : 254 7
14. Mellemgaard A, Carstensen B, Norgaard N, Knudsen JB, Olsen JH. Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943-88. Scand J Urol Nephrol 1993 27 : 327 32
15. Chen CJ, Hsueh YM, Lai MS et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995 25 : 53 60
16. Linet MS, Chow WH, McLaughlin JK et al. Analgesics and cancers of the renal pelvis and ureter. Int J Cancer 1995 62 : 15 8
17. Liaw KL, Linet MS, McLaughlin JK et al. Possible relation between hypertension and cancers of the renal pelvis and ureter. Int J Cancer 1997 70 : 265 8
18. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999 33 : 1011 7
19. Nortier JL, Martinez MC, Schmeiser HH et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000 342 : 1686 92
20. Tseng CH. Blackfoot disease and arsenic: a never-ending story. J Environ Sci Health 2005 23 : 55 74
21. Mills C, Vaughan ED Jr. Carcinoma of the ureter: natural history, management and 5-year survival. J Urol 1983 129 : 275 7
22. Kang CH, Yu TJ, Hsieh HH et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003 98 : 1620 6
23. Krambeck AE, Thompson RH, Lohse CM et al. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. J Urol 2007 177 : 1721 6
24. McCarron JP, Mills C, Vaughn ED Jr. Tumors of the renal pelvis and ureter: current concepts and management. Semin Urol 1983 1 : 75 81
25. Landman J, Lev RY, Bhayani S et al. Comparison of hand assisted and standard laparoscopic radical nephroureterectomy for the management of localized transitional cell carcinoma. J Urol 2002 167 : 2387 91
26. Reitelman C, Sawczuk IS, Olsson CA, Puchner PJ, Benson MC. Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter. J Urol 1987 138 : 1144 5
27. Ozsahin M, Zouhair A, Villa S et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 1999 35 : 738 43
28. Holmang S, Johansson SL. Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer. Scand J Urol Nephrol 2006 40 : 479 84
29. Heney NM, Nocks BN, Daly JJ, Blitzer PH, Parkhurst EC. Prognostic factors in carcinoma of the ureter. J Urol 1981 125 : 632 6
30. Wallace DM, Wallace DM, Whitfield HN, Hendry WF, Wickham JE. The late results of conservative surgery for upper tract urothelial carcinomas. Br J Urol 1981 53 : 537 41
31. Huang PC, Huang CY, Huang SW et al. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan. Int J Urol 2006 13 : 864 9
32. Joudi FN, Crane CN, O'Donnell MA. Minimally invasive management of upper tract urothelial carcinoma. Curr Urol Rep 2006 7 : 23 30
33. Chew BH, Pautler SE, Denstedt JD. Percutaneous management of upper-tract transitional cell carcinoma. J Endourol/Endourol Soc 2005 19 : 658 63
34. Park S, Meng MV. Endoscopic and minimally invasive approaches to upper tract urothelial carcinoma. Curr Opin Urol 2005 15 : 336 41
35. Shiong Lee L, Yip SK, Hong Tan Y, Cheng CW. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. Scand J Urol Nephrol 2006 40 : 283 8